[Association between Cerebral Small Vessel and Alzheimer's Disease]

Insights

Cerebral small vessel disease (CSVD) is linked to Alzheimer's disease (AD) biomarkers. Understanding this association is key for developing new therapies targeting vascular contributions to AD.

Area of Science:

  • Neurology
  • Radiology
  • Biochemistry

Context:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
  • Cerebral small vessel disease (CSVD) encompasses various cerebrovascular lesions detectable via MRI.
  • Emerging evidence suggests a significant link between vascular health and AD pathogenesis.

Purpose:

  • To review the current understanding of the association between CSVD and AD.
  • To explore the relationship between CSVD, AD, and key AD biomarkers (amyloid-beta and tau).
  • To highlight the potential therapeutic implications of targeting vascular factors in AD.

Summary:

  • CSVD lesions on MRI, including white matter hyperintensities and microbleeds, are associated with amyloid and tau pathology in AD.
  • The review details CSVD pathogenesis and characteristic MR imaging findings.
  • The interplay between vascular changes and neurodegeneration in AD is examined.

Impact:

  • Provides a comprehensive overview for researchers and clinicians.
  • Emphasizes the importance of vascular contributions to AD.
  • Informs potential therapeutic strategies for AD by focusing on vascular interventions.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
628
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
155
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
247